1-phenyl-2-decanoylamino-3-morpholino-1-propanol has been researched along with Adult GM1 Gangliosidosis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bagnoli, S; Cascella, R; Cecchi, C; Evangelisti, E; Fiorillo, C; Nacmias, B; Nichino, D; Relini, A; Scartabelli, T; Sorbi, S; Wright, D; Zampagni, M | 1 |
1 other study(ies) available for 1-phenyl-2-decanoylamino-3-morpholino-1-propanol and Adult GM1 Gangliosidosis
Article | Year |
---|---|
Lipid rafts mediate amyloid-induced calcium dyshomeostasis and oxidative stress in Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Analysis of Variance; Animals; Calcium; Cells, Cultured; Cerebral Cortex; Cholera Toxin; Embryo, Mammalian; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Fibroblasts; Gangliosidosis, GM1; Humans; Lipid Peroxidation; Membrane Microdomains; Morpholines; Mutation; Neurons; Oxidative Stress; Peptide Fragments; Presenilin-1; Rats; Rats, Sprague-Dawley | 2013 |